Psychiatric Medication, Practically

What Happens If You Just Stop Strattera

Save

Stopping Strattera (atomoxetine) doesn't cause the stimulant crash or classic withdrawal seen with other ADHD or antidepressant medications. Instead, ADHD symptoms tend to gradually return as the drug clears. This article explains what to expect, how to tell it apart from something else, and why planning still matters.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

Does Strattera cause a withdrawal syndrome like stimulants or antidepressants do?

Atomoxetine (Strattera) is a non-stimulant, and it doesn't produce the same abrupt "crash" associated with stopping stimulant ADHD medications, nor the well-documented discontinuation syndrome described for many antidepressants 1. It works on norepinephrine through a different mechanism than either of those drug categories, and the research on stopping it doesn't describe a defined, predictable withdrawal pattern the way SSRI or stimulant discontinuation research does. That's a genuinely different picture than what happens after a stimulant crash, which is worth knowing if you've taken both kinds of ADHD medication before. It shares that "milder than you'd expect" quality with some other psychiatric medications, like buspirone, though the underlying reasons differ.

What actually happens when atomoxetine leaves your system?

What most people notice after stopping atomoxetine isn't a withdrawal syndrome in the classic sense -- it's the gradual return of whatever ADHD symptoms the medication had been managing: difficulty sustaining attention, disorganization, impulsivity, or restlessness creeping back in over days to a couple of weeks as the drug clears your system. General medication references describe atomoxetine's mechanism as distinct from both stimulants and antidepressants 2, consistent with this different stopping pattern. That's the medication's effect wearing off, not a rebound or discontinuation reaction layered on top of it. The distinction matters, because it changes what the "getting back to baseline" experience should actually feel like.

How would you tell returning ADHD symptoms from something else?

Returning ADHD symptoms tend to look like a gradual re-emergence of your familiar patterns -- the same struggles you had before starting atomoxetine, at roughly the same intensity, rather than new physical sensations. If instead you notice things that feel genuinely new -- dizziness, flu-like aches, unusual irritability that doesn't match your prior ADHD picture -- that's worth mentioning directly to your prescriber rather than assuming it's simply "ADHD coming back," since it doesn't fit the expected pattern as cleanly, and a genuinely new symptom deserves its own explanation rather than a convenient one.

Why isn't 'no crash' the same as 'no reason to plan it'?

The absence of a dramatic crash doesn't mean stopping atomoxetine is something to do without a plan. Functional changes -- work performance, driving safety, relationships, school -- can shift meaningfully as ADHD symptoms return, even without any physical withdrawal at all, and that's a real consequence worth planning around with your prescriber rather than discovering after the fact. Reviews of psychotropic medication discontinuation broadly note that functional impact and physical withdrawal are separate questions 3 -- a medication can be easy on the body to stop while still being hard on your week if the symptoms it managed come back at an inconvenient time. Thinking through which responsibilities depend most on steady attention, and lining up support for those in advance, tends to make the transition considerably smoother.

Making the stop a shared decision

Strattera's lack of a classic withdrawal syndrome is one of its more reassuring features, but it doesn't remove the value of deciding to stop together with your prescriber, who can help you anticipate how returning symptoms might show up in your specific daily life and what support makes sense during that transition. If you're also managing timing questions around a missed dose or gap, staying ahead of psych med refills covers the logistics side of that same conversation, and is worth reading even for a non-stimulant medication like this one.

Common questions

No -- atomoxetine is a non-stimulant and doesn't produce the same abrupt crash pattern associated with stopping stimulant ADHD medications; what most people notice instead is a gradual return of ADHD symptoms.

This varies by person, but symptoms returning over days to a couple of weeks as the medication clears is a commonly described pattern, rather than an abrupt same-day change.

The research doesn't describe atomoxetine as requiring a specific taper the way some antidepressants do, but any decision to stop should still go through your prescriber, who can factor in your dose, duration, and health history.

Possibly -- symptoms that feel physically new rather than like your familiar ADHD pattern are worth flagging to your prescriber rather than assuming they're simply symptoms returning.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

If things feel heavy, a person is available anytime — call or text 988.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

If stopping Strattera doesn't go the way you expected

  • —New physical symptoms unlike your usual ADHD pattern
  • —Sudden, severe mood changes
  • —Functional decline that feels unsafe -- at work, school, or while driving
  • —Thoughts of self-harm or suicide

Atomoxetine's discontinuation pattern is generally described as milder than stimulant or antidepressant withdrawal, but individual experiences vary. This is general information, not medical advice. If you are in crisis, call or text 988 (Suicide & Crisis Lifeline), free and available 24/7.

References

  1. 1.Cosci F, Chouinard G (2020). Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications. Psychotherapy and Psychosomatics. doi:10.1159/000506868 ✓withdrawal-syndromepsychotropic-discontinuationprotracted-withdrawal
  2. 2.National Institute of Mental Health (NIMH) (2024). Mental Health Medications. National Institute of Mental Health (NIMH). link ✓ssri-anti-anxiety-medsptsd-medicationdepression-treatmentdrinking-on-antidepressants
  3. 3.Davies J, Read J (2019). A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: Are guidelines evidence-based?. Addictive Behaviors. doi:10.1016/j.addbeh.2018.08.027 ✓antidepressant-withdrawalwithdrawal-durationguidelines

3 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy

← Back to the health library